PD-1 and CTLA-4, the two most commonly studied checkpoints, are not functionally redundant and while they both act to modulate distinct populations of tumour-infiltrating lymphocytes (TILs), including CD4+, CD8+, regulatory T (Treg) cells, they do so with different mechanistic profiles. Here, CD8A is linked to neoplasm.